FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
Oppenheimer analyst Steven Lichtman raised the price target on Insulet Corporation (NASDAQ: PODD) to $335.00 (from $280.00) while maintaining a Outperform rating.
The analyst commented, "PODD's 4Q22 sales of $369.7M (+22.6% cc) far exceeded our/Street's ~$333M/$327M estimates. US Omnipod at $276.2M beat our... More
Insulet (NASDAQ: PODD) reported Q4 EPS of $0.24, $0.03 better than the analyst estimate of $0.21. Revenue for the quarter came in at $369.7 million versus the consensus estimate of $332.18 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
... More
